Therapeutic apheresis system
Gray , et al. January 5, 2
U.S. patent number D746,988 [Application Number D/523,524] was granted by the patent office on 2016-01-05 for therapeutic apheresis system. This patent grant is currently assigned to Parker-Hannifin Corporation. The grantee listed for this patent is Parker-Hannifin Corporation. Invention is credited to Michael Collinson, Paul Gray.
| United States Patent | D746,988 |
| Gray , et al. | January 5, 2016 |
Therapeutic apheresis system
Claims
CLAIM The ornamental design for a therapeutic apheresis system, as shown and described.
| Inventors: | Gray; Paul (Dunstable, GB), Collinson; Michael (Camarillo, CA) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Applicant: |
|
||||||||||
| Assignee: | Parker-Hannifin Corporation
(Cleveland, OH) |
||||||||||
| Appl. No.: | D/523,524 | ||||||||||
| Filed: | April 10, 2015 |
Related U.S. Patent Documents
| Application Number | Filing Date | Patent Number | Issue Date | ||
|---|---|---|---|---|---|
| 29483525 | Feb 28, 2014 | D731066 | |||
| Current U.S. Class: | D24/169 |
| Current International Class: | 2401 |
| Field of Search: | ;D24/169,186,107,108,111,216,219,232 ;604/27,29,131,132,140,141,146,6.01-6.05,6.11,6.13-6.16,151 |
References Cited [Referenced By]
U.S. Patent Documents
| 5112298 | May 1992 | Prince |
| D446860 | August 2001 | Meziere |
| D446861 | August 2001 | Meziere |
| D540948 | April 2007 | Meziere |
| D550373 | September 2007 | Meziere |
| D619241 | July 2010 | Olsson |
| D633619 | March 2011 | Collins |
| D694396 | November 2013 | Belt |
| 2004/0186416 | September 2004 | Caleffi |
| 2005/0070837 | March 2005 | Ferrarini |
Attorney, Agent or Firm: Renner, Otto, Boisselle & Sklar, LLP
Description
FIG. 1 is a perspective view of the therapeutic apheresis system showing our new design.
FIG. 2 is a front view thereof.
FIG. 3 is a back view thereof.
FIG. 4 is a left side view thereof.
FIG. 5 is a right side view thereof.
FIG. 6 is a top view thereof; and,
FIG. 7 is a bottom view thereof.
The broken lines in the drawings represent unclaimed portions of the therapeutic apheresis system and form no part of the claimed design.
* * * * *
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 